Phase II clinical study of modified FOLFOX7 (intermittent oxaliplatin administration) plus bevacizumab in patients with unresectable metastatic colorectal cancer—CRAFT study

Purpose Continuous treatment with FOLFOX therapy is associated with peripheral nerve toxicity, and to improve this inconvenient side effect various methods of administration are being investigated. A regimen of intermittent oxaliplatin administration by continuous infusion therapy, i.e., modified FO...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tezuka, Tohru, Hamada, Chikuma, Ishida, Hideyuki, Ooshiro, Mitsuru, Matsuoka, Hiroshi, Kawasaki, Shingo, Mishima, Hideyuki, Maeda, Kotaro, Sakamoto, Junichi, Koda, Keiji
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2013
Assuntos:
Phase II Studies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3771374/
https://ncbi.nlm.nih.gov/pubmed/23817973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-013-9982-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados